Frontlight ResearchEarly access
Head and neck cancer trials in China
216 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleNeoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05069857 - Phase 2/3Taking peopleNeoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05125055 - Phase 3Taking peopleEvaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
- Where
- Beijing
- Age
- 18 years and over
- People
- 272
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06102395 - Phase 2Taking peoplePenpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
- Where
- Changchun, Shanghai
- Age
- 18 years to 80 years
- People
- 48
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT05260671 - Phase 2Taking peoplePostoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy
- Where
- Beijin
- Age
- 18 years to 75 years
- People
- 84
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05777824 - Phase 2Taking peopleNeoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 82
- Run by
- Fudan University
See details and how to joinNCT06039631 - Phase 2Taking people4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 192
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05980702 - Phase 2Not yet taking people in ChinaAdelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06016413 - Phase 2Not yet taking people in ChinaNeoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 33
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT05993858 - Phase 3Taking peoplePD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy
- Where
- Guangzhou
- Age
- 18 years to 65 years
- People
- 324
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05980715 - Phase 2Taking peopleNeoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma :A Single-arm, Prospective, Phase II Trial
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Weijia Fang, MD
See details and how to joinNCT05862168 - Phase 2Taking peopleTirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC
- Where
- Guangzhou
- Age
- 18 years to 65 years
- People
- 100
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05941338 - No phaseTaking peopleThe Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR
- Where
- Zhuhai
- Age
- 18 years to 70 years
- People
- 23
- Run by
- Fifth Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT05854823 - Phase 2Taking peopleNeoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 57
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT04807140 - Phase 2Taking peopleA Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 41
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT04992559 - No phaseNot yet taking people in ChinaRadiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 158
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT03358602